chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, Myalgia, Extreme fatigue, pain and swelling in left leg at site of previous blood clot, Narrative: Employee advised to seek medical evaluation due to report of pain/swelling in her leg at site of previous blood clot
Pt got a Moderna shot instead of flu shot in error. Pt has already received 2 doses of Moderna on 3/19/21 & 4/14/2021.
This spontaneous report was received from a pharmacist refers to a 63 year old patient of age gender. On 23-OCT-2014, the patient was vaccinated with ZOSTAVAX, subcutaneous (Lot # reported as K00884, expiration date reported as 13-MAR-2015). The reporter stated that patient received ZOSTAVAX that was improperly exposed to 29F for 19 hours 40 minutes. No known adverse effects was reported. No product quality complaint was involved. This is one of several reports from the same reporter source. Additional information has been requested.
The patient developed a reddened area on the left arm the size of a 1/2 dollar approximately 2 to 3 hours after the injection. On 09/04/2001 the patient experienced vomiting. On 09/05/2001 the patient's temperature was 104F. The patient was treated with Tylenol and Benadryl.
This spontaneous report was received from a medical assistant and refers to a 14 year old male patient. The patient's concurrent conditions and medical history were not reported. On 06/24/2014, the patient was vaccinated with GARDASIL 9 first dose (dose, route, lot number and expiry date were not reported) for prophylaxis. Later, on 26-JUL-2015, the patient received his second dose of GARDASIL 9 (dose, route, lot number and expiry date were not reported) for prophylaxis. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information is not expected, because the reporter did not allow any follow up contact with the physician.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with a 0.5 ml dose of GARDASIL (dosing information and lot number not provided). The physician stated that the patient fainted after the vaccination. Unspecified medical attention was sought. It was unknown if there were lab studies performed. On an unspecified date, the patient recovered. Additional information has been requested.
approx 24 hrs p/vax pt exp sl achiness & warmth 48 hrs later  had t102-104, myalgias, arthralgias, h/a; lasted 4-5 days according to client;
89 year old male who presents from local medical care facility due to lethargy and fever. COVID positive 8/28/22, vaccinated 3/6/21, 2/13/21.
Mild side effect; Around 6 am they noticed a water blister on the left knuckle and around 10:15 am they got another one on the right knuckle. Both are pretty big in size, and Patient states it is hard to work; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Around 6 am they noticed a water blister on the left knuckle and around 10:15 am they got another one on the right knuckle. Both are pretty big in size, and Patient states it is hard to work) and VACCINATION COMPLICATION (Mild side effect) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 006M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for Cholesterol, AMLODIPINE and LISINOPRIL for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced BLISTER (Around 6 am they noticed a water blister on the left knuckle and around 10:15 am they got another one on the right knuckle. Both are pretty big in size, and Patient states it is hard to work). On an unknown date, the patient experienced VACCINATION COMPLICATION (Mild side effect). At the time of the report, BLISTER (Around 6 am they noticed a water blister on the left knuckle and around 10:15 am they got another one on the right knuckle. Both are pretty big in size, and Patient states it is hard to work) and VACCINATION COMPLICATION (Mild side effect) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable No treatment medication were reported.   This case was linked to MOD21-070766 (E2B Linked Report).; Sender's Comments:  MOD21-070766:Crosslink
Vomits, stomach pain, abdominal pain, diarrhea, fever, high presure, gastritis. Excess of urine, headache, rash, could not swallow, gain weight, not sleeping, gas, belching. For 2 months I went to the doctor with this feelings the worst was a gastritis and poo every day like 8 times. Itch don't go yet. Pharmacy - SHINGRIX on May 24 - first part. Next dose is supposed to be in two month. But they say don't have it. I went 3 times ask the pharmacist about the reaction if some more having troubles. They say no. Asked for the papers but he said he was going to pass directly to Dr. Pharmacy - waiting for second dose. They don't have it.
Information has been received from a published article. Abstract: The human papillomavirus quadrivalent (types 6, 11, 16, and 18) recombinant vaccine is effective in preventing cervical, vulva, vaginal and anal cancer. Maximal protection is achieved with completion of all three recommended doses. A retrospective chart review was performed to assess the current vaccine series completion rates in a private practice multispecialty suburban setting and identify factors associated with failure to complete the vaccine series. Chi-square and independent samples t test were used for data analysis. A total of 4,117 patients out of 10,821 eligible patients received at least one dose of the HPV vaccine between 01-OCT-2006 and 30-APR-2010. Overall, 69.5% (n = 2,863) of patients who received one dose of the HPV vaccine completed all three doses in a valid time frame, representing 26.5% of all eligible patients. Patients who completed the series were younger (16.8 vs. 18.2, p < 0.05), less likely to have a sexually transmitted disease diagnosis prior to initiation of the series (57.7 vs. 69.8%, p < 0.05), and more likely to have visited the pediatrics department compared to family medicine, internal medicine, and OB/GYN departments (75.9, 65.7, 57.0, 60.9%, respectively, p < 0.05). Deaths, pregnancies, and adverse drug reactions were not identified as independent factors impacting completion rates. The results indicate that adolescents, patients visiting the pediatrics department and those without a prior STD diagnosis completed the vaccination series more frequently than adults managed in family medicine, internal medicine, and OB/GYN departments. Result: The review of the randomly selected 10% sample of 411 patient charts for adverse reactions identified four patients (less than one percent) who experienced an adverse event within 30 days of vaccine administration. Two patients reported an injection site reaction, which is the most common documented ADR for HPV vaccination. One patient reported a systemic viral infection and one patient reported a genital HPV infection, neither of which was determined to be related to the vaccine. Of the four patients who experienced an adverse event, one completed the series and three patients did not. This report concerns the 2 patients that reported injection site reaction which is most common documented ADR for HPV vaccination. Event outcome was not mentioned. No further information is available.
Diagnosed with left ear infection after first covid shot. Ear ringing, throbbing aching sensation.  Prescribed  Amox Clav 875 MG  twice daily for 10 days. After 2nd Covid shot symptoms spread to both ears. Diagnosed with ear infection in both ears. Prescribed Sulfameth/Trimeth 400-80 MG tablets, 1 tablet daily for 7 days.
Patient received the COVID-19 Vaccine. She reports symptoms of sudden onset headache and dizziness upon walking.  Patient stated she has a history of multiple allergies in the past.  She also endorsed a "funny taste in my mouth."  Patient taken to observation triage area for further assessment.   Patient did not appear pale or diaphoretic, breathing with no difficulty, no swelling noted, no rash or itching, no nausea or vomiting. Vitals a follows: 10:40 B/P 131/84 HR 74 O2 98 10:45 B/P 127/77 HR 70 O2 99 10:50 B/P 127/67 HR 72 O2 99 10:55 B/P 126/65 HR 67 O2 99 11:00 B/P 125/75 HR 71 O2 99.   Patient also stated that she did not eat. Patient received the COVID-19 Vaccine. She reports symptoms of sudden onset headache and dizziness upon walking.  Patient stated she has a history of multiple allergies in the past.  She also endorsed a "funny taste in my mouth."  Patient taken to observation triage area for further assessment.   Patient did not appear pale or diaphoretic, breathing with no difficulty, no swelling noted, no rash or itching, no nausea or vomiting. Vitals a follows: 10:40 B/P 131/84 HR 74 O2 98 10:45 B/P 127/77 HR 70 O2 99 10:50 B/P 127/67 HR 72 O2 99 10:55 B/P 126/65 HR 67 O2 99 11:00 B/P 125/75 HR 71 O2 99.   Patient also stated that she did not eat or drink anything prior to coming into clinic for her vaccine.  Given a bottle of water and 2 crackers and felt better.  Patient ambulated with steady gait in no apparent distress and went home safely.t or drink anything prior to coming into clinic for her vaccine.  Given a bottle of water and 2 crackers and felt better.  Patient ambulated with steady gait in no apparent distress and went home safely.
Saturday evening, I had congestion in my upper chest. Early Sunday morning I went to the local clinic to be tested for COVID-19 that came back positive. The test came back positive, I was prescribed ivermectin, a Z-PAK and prednisone. I called my doctor on Monday and he told me that it was okay to take the ivermectin, but he also prescribed the PAXLOVID. I am still coughing up a lot of mucus as the congestion is in the middle of my lungs. I am still fatigued.
May 28th, my period started and lasted for 16 days. It is usually 6-8 days. I had no other symptoms. No hot flashes. No mood disturbances. No fatigue. Just the long period.
Patient complains that she has continued to have persistent pain in her arm and shoulder. The pain is intense and almost debilitating. Pt is scheduled to see her physician for a follow up.
Information has been received from a healthcare worker reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions/allergies, pertinent medical history or concomitant medication. On 06-JAN-2017, the patient received an improperly stored dose of LIQUID PEDVAXHIB lot # N012120, expiration date 30-JAN-2020 or lot # N000235, expiration date 26-OCT-2019 or lot # N007749, expiration date 29-NOV-2019 for prophylaxis (dose, anatomical location and route of administration were not reported). It was reported that on an unspecified date, the vaccine was exposed to a temperature between 9 Celsius degrees and 25 Celsius degrees for 47 hours and 39 minutes. The vaccine did not undergo a previous temperature excursion. The call was placed because of a Digital Data logger report. No adverse effects were reported. This report is one of multiple reports received from the same reporter.; Sender's Comments: US-009507513-1711USA006083: US-009507513-1711USA013916: US-009507513-1711USA013917: US-009507513-1711USA013918: US-009507513-1711USA013919: US-009507513-1711USA013920: US-009507513-1711USA013921: US-009507513-1711USA013913: US-009507513-1711USA013914:
Information has been received from a nurse practitioner via a field representative referring to a 21 year old female patient. The patient's pertinent medical history and drug reactions/allergies were not reported. On 28-JUL-2015 the patient was vaccinated with her first dose of GARDASIL 9 lot # K026246 (dose, route, and expiration date were not reported). Information regarding concomitant medication was not reported. On 29-JUL-2015 or 30-JUL-2015, a day or two after the patient received her first dose of GARDASIL 9, she got a high fever of 103 Fahrenheit, swollen lymph nodes, and general fatigue. The patient sought medical attention via phone call. On 14-AUG-2015, the patient came in to see the nurse practitioner. No lab diagnostics studies were performed. The patient was completely recovered on an unspecified date of 2015. The causality was not reported. Additional information has been requested.
shortness of breath, heavy chest, rapid heartbeat, skipping heartbeat, talked to cardiologist
allergies; This spontaneous case was reported by a patient and describes the occurrence of HYPERSENSITIVITY (allergies) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included Disease risk factor (steroids and antihistamines).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (allergies). At the time of the report, HYPERSENSITIVITY (allergies) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported, treatment medication were not reported
Patient presented to clinic for an RSV vaccination as prescribed by her OB/GYN provider. She was given Arexvy. Being pregnant, she should have received Abrysvo. This vaccine was not available in the clinic. Experienced localized reaction - redness and sore at injection site. She is 34 weeks gestation. Due date is December 4, 2023
Developed generalized pruritus 5 minutes after receiving the vaccine. Received 25mg of diphenhydramine with resolution of symptoms. No rash. No other symptoms.
Blurred vision, benign vertigo, immediately after vaccine given.  Corrected itself over the next hour. But at 4:30 am  2/22/2021 I was awakened by intense  itching on my left arm and hand.  Over the next 2 hours the itching increased in intensity and progressed to my right arm and hand, over my upper back and shoulders, and along the back of my thighs and buttocks.        I took 2 Benadryl allergy tablets (25mg) and used Benadryl GEL extra strength on the affected areas.  This resulted in my sleepiness for the remainder of the day. Contacted my physicians office for an appointment to resolve the issue.
Headache, chills and body aches from ~10 to 72 hours post-dose; nausea ~13-14 hours post-dose and 4-5 days post-dose; 3 itchy, red, blistery spots on right abdomen.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 05-OCT-2016, the patient was vaccinated with the first dose of ZOSTAVAX injection, subcutaneously (lot# L046295 and expiration date 17-FEB-2017, dose not provided). On 09-JAN-2017, the patient was vaccinated with the second dose of ZOSTAVAX injection, subcutaneously (lot# M033336 and expiration date 11-OCT-2017, dose not provided). No adverse effects were reported. Additional information has been requested.
Patient received Pfizer COVID vaccine on 3/29/21 (lot # ER8730), 4/19/21 (lot # ER8735), and 11/8/21 (lot # FG3527). On 5/9/22, patient admitted to our inpatient facility acute hypoxic respiratory failure, COVID 19 pneumonia, probably pneumocystis pneumonia, HIV/AIDS, and oral thrush. Patient also tested positive for COVID on admission. As of today (5/16/22), patient is still admitted in our med/surg unit.
Had severe pain at/near the site of the injection, and could not lift my arm or move it without that pain for approximately 12 hrs.  My arm remained sore for about 24 hrs thereafter. Also had lymph system respond; experienced swelling under arms. Arm experienced stiffness and tenderness around the injection site for two plus weeks after injection.
None: Expired Vaccine 10/25/2022; given on 02/01/2023
Patient complained of dizziness and nausea.  She said she has a headache.  Responders saw her slowly walk to her seat ahd she tripped.  She looked faint when they helped her up.  Her blood pressure was 107/74.  She was given IV fluids and transported to medical center
left eye is swollen; right arm is very sore; throat is a little sore; This is a spontaneous report from a contactable consumer or other non hcp (parent) via Pfizer-sponsored program. A 17-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number was not reported, Expiry date was not reported), via an unspecified route of administration, administered in Arm Right on 19Jul2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. It was reported that the patient got his first dose of the Pfizer BioNTech covid 19 vaccine 2 days ago, and that his left eye is swollen (on the bottom and down, almost as if he'd been punched), was real puffy and his right arm is very sore (injection was on the right). She wants to know if it's a normal reaction. She confirms what study relayed, that he does have some kind of abnormality with his eye as underlying condition, which is that he gets allergies associated with conjunctivitis, but this does not look like that. She also stats that his throat is a little sore, but does not have a fever. The outcome for the events was unknown.  Information about the Lot/batch number has been requested.
Patient's mother reported to office on 11-7-11 that the patient had approx. 125 lesions (presumed to be from chickenpox) on his back, face, abdomen, neck, and thighs. No fever or other 'symptoms'. Advised to seek medical attention if symptoms worsen.
Patient developed red, indurated area at site of vaccine 6x10cm. She developed aches and temp 100. No other symptoms.
Information has been received from a physician concerning a 38 year old female patient with no drug reactions or allergies and a history of sarcoidosis who on approximately 06-SEP-2010 was vaccinated with her first 0.5ml dose of PNEUMOVAX 23 (Lot # not provided). Concomitant therapy included IMURAN. The physician reported that on approximately 07-SEP-2010 "the next day", that the patient received the dose of PNEUMOVAX 23, she was experiencing "red streaks", hot, swollen and isolated movement in the arm that she was vaccinated in". The patient sought unspecified medical attention. At the time of report, the patient's outcome was unknown. Follow-up information was received from a licensed practical nurse who reported that the 38 year old female patient with a history of sarcoidosis and fibromyalgia, on 17-SEP-2010, was administered a dose of PNEUMOVAX 23 (lot # 667912/0933Z, expiry date on 25-FEB-2012), intramuscularly into her right deltoid in the morning. The nurse stated that the morning of 19-SEP-2010, the patient experienced redness, heat, swelling and isolated movement at the injection site, with red streaks toward the elbow. On 20-SEP-2010, at 08:30 A.M., the patient went to the physician's office. On 22-SEP-2010, the patient recovered. No further information is available.
Lips felt tingly 2 hours after injection; Swelling occurred on  two of lip injection sites; Right bottom lip has a "bump" as wellas top right lip; This is a spontaneous report from a contactable consumer, the patient. A 48-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the arm left on 30Mar2021 at 15:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included brain aneurysm. The patient was allergic to fentanyl, Versed and bees. The patient's past therapy included Juvederm injections in Aug2020. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 18:30, the patient's right bottom lip had a bump as well as top right lip. The patient's lips felt tingly 2 hours after injection then swelling occurred on two of lip injection sites. The bumps were very small. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tingling lips, swollen lips and bumps lip was unknown.   No follow-up attempts are needed. No further information is expected.
Suddenly felt nauseous, weak/faint with profuse sweating and tunnel vision followed by severe diarrhea and inability to stand up for about an hour.
First 10 seconds immediate swelling. A minute and a half increasing pain in the arm. Next 10 minutes flushed and tingly or loopy systemically.  After 15 minutes not flushed but still light feeling. Returned inside the clinic to have blood pressure checked. It was abnormal at 147 something. They advised going to the emergency room. An ambulance came and my blood pressure continued to rise to 157. In ER they did an EKG. Blood pressure continue to rise but heart rate was extremely low in the 40s.  Stayed for 4 and 1/2 hours. The highest blood pressure was at 174/86. Lowest heart rate was 40. The doctor tried Xanax but it did not lower much of the blood pressure. It did decrease some to 148 to 164. Heart rate did go up to 50s and 60s but still dropped to 40s. They released me because they had no answers and the labs came back fine. I could not drive because of the Xanax made me feel worse. So I had someone drive me home. I am to follow up tomorrow with my primary care doctor to check my blood pressure and see what else can be done.
Patient reports pain 7/10 in the deltoid muscle when she lifts her arm laterally. No pain when lifting arm ventrally/dorsally. Verified it's muscle pain and not joint pain associated with injection bursitis. She confirms it's muscle pain. Somewhat interferes with daily activites and has to be careful. No redness or swelling present at the site of injection. Soreness has not improved or worsened in the last month.
**EXTREME** fatigue the following morning.  It was an extraordinary sense of fatigue that I have not experienced before Soreness in the arm(s) and upper back with both doses - I did take pain relief after second dose which helped tremendously